The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Catlett, I. M.
Right arrow Articles by Bishop, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Catlett, I. M.
Right arrow Articles by Bishop, G. A.
The Journal of Immunology, 2001, 166: 6019-6024.
Copyright © 2001 by The American Association of Immunologists

Signaling Through MHC Class II Molecules Blocks CD95-Induced Apoptosis1

Ian M. Catlett*, Ping Xie*, Bruce S. Hostager* and Gail A. Bishop2,*,{dagger},{ddagger},§

Departments of * Microbiology and {dagger} Internal Medicine and {ddagger} Graduate Program in Immunology, University of Iowa, and § Veterans Affairs Medical Center, Iowa City, IA 52242

B cells are induced to express CD95 upon interaction with T cells. This interaction renders the B cells sensitive to CD95-mediated apoptosis, but ligation of proviability surface receptors is able to inhibit apoptosis induction. MHC class II is a key molecule required for Ag presentation to Th cells, productive T cell-B cell interaction, and B cell activation. We demonstrate here for the first time that MHC class II ligation also confers a rapid resistance to CD95-induced apoptosis, an affect that does not require de novo protein synthesis. Signaling through class II molecules blocks the activation of caspase 8, but does not affect the association of CD95 and Fas-associated death domain-containing protein. MHC class II ligation thus blocks proximal signaling events in the CD95-mediated apoptotic pathway.




This article has been cited by other articles:


Home page
Int ImmunolHome page
M. A. Kriegel, S. Adam-Klages, C. Gabler, N. Blank, M. Schiller, C. Scheidig, J. R. Kalden, and H.-M. Lorenz
Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy
Int. Immunol., April 1, 2008; 20(4): 601 - 613.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Chattopadhyay, A. Q. Khan, G. Sen, J. Colino, W. duBois, A. Rubtsov, R. M. Torres, M. Potter, and C. M. Snapper
Transgenic Expression of Bcl-xL or Bcl-2 by Murine B Cells Enhances the In Vivo Antipolysaccharide, but Not Antiprotein, Response to Intact Streptococcus pneumoniae
J. Immunol., December 1, 2007; 179(11): 7523 - 7534.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Stoicov, X. Cai, H. Li, K. Klucevsek, J. Carlson, R. Saffari, and J. Houghton
Major Histocompatibility Complex Class II Inhibits Fas Antigen-Mediated Gastric Mucosal Cell Apoptosis through Actin-Dependent Inhibition of Receptor Aggregation
Infect. Immun., October 1, 2005; 73(10): 6311 - 6321.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. O. Nashar and J. R. Drake
The Pathway of Antigen Uptake and Processing Dictates MHC Class II-Mediated B Cell Survival and Activation
J. Immunol., February 1, 2005; 174(3): 1306 - 1316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. S. Hostager, S. A. Haxhinasto, S. L. Rowland, and G. A. Bishop
Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)-deficient B Lymphocytes Reveal Novel Roles for TRAF2 in CD40 Signaling
J. Biol. Chem., November 14, 2003; 278(46): 45382 - 45390.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B.-C. Yang, H.-K. Lin, W.-S. Hor, J.-Y. Hwang, Y.-P. Lin, M.-Y. Liu, and Y.-J. Wang
Mediation of Enhanced Transcription of the IL-10 Gene in T Cells, Upon Contact with Human Glioma Cells, by Fas Signaling Through a Protein Kinase A-Independent Pathway
J. Immunol., October 15, 2003; 171(8): 3947 - 3954.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.